IBI-3027

N/A

Report date: 2026/05/16 20:00:17

Base Information

Drug NameIBI-3027
Drug Alias NameIBI3027IBI-3027
ClassificationBiologics > Biosimilar
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPrurigo NodularisDermatitis, AtopicPulmonary Disease, Chronic Obstructive +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInnovent Biologics(Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnovent Biologics(Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsPrurigo NodularisDermatitis, AtopicPulmonary Disease, Chronic Obstructive +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A